| 76.1 | B01AD01 | streptokináza (do 0,75 MU včetně v jedné dávce) | parent. | 1.5 | MU | 3608,44 | U |
| 10937 | STREPTASE | inj sic 1x750 ku | BEH | D |
| 76.2 | B01AD01 | streptokináza (nad 0,75 MU v jedné dávce) | parent. | 1.5 | MU | 3426,91 | U |
| 94697 | KABIKINASE | inj sic 1x1.5mu | KBP | S |
| 62461 | STREPTASE | inj sic 1x1.5 MU | HMD | D |
| 76.3 | B01AD02 | alteplaza | parent. | 0.1 | GM | 43265,44 | U/P |
| 76.4 | B01AD04 | urokináza (do 100 kU v jedné dávce včetně) | parent. | 3 | MU | 53928,40 | U/P |
| 97843 | UKIDAN | inj.100ku +2ml solv | SRO | CH |
| 76.5 | B01AD04 | urokináza (nad 500 kU v jedné dávce) | parent. | 3 | MU | 42565,93 | U/P |
| 76.6 | B01AD04 | urokináza (nad 100 do 500 kU v jedné dávce) | parent. | 3 | MU | 45346,56 | U/P |
| 76.7 | B01AD07 | retepláza | parent. | 20 | U | 43265,44 | U/P |
| 77 | B02AA | antifibrinolytika ze skupiny aminokyselin | p.o. |
|---|
| 77.1 | B02AA01 | kyselina aminokaproová | p.o. | 16 | GM | 38,86 | |
| 77.2 | B02AA02 | kyselina tranexámová (do 250 mg v jedné tabletě včetně) | p.o. | 2 | GM | 40,72 | |
| 77.3 | B02AA02 | kyselina tranexámová (nad 250 mg v jedné tabletě) | p.o. | 2 | GM | 38,57 | |
| 97410 | EXACYL | tbl fc 20x500mg | SFH | F |
| 97412 | EXACYL | sol 5x10 ml/1gm | KBP | S |
| 57480 | EXACYL | tbl obd 20x500 mg | SWP | P |
| 77.4 | B02AA03 | kyselina aminomethylbenzoová | p.o. | 0.25 | GM | 20,14 |
| 02123 | PAMBA | tbl 10x250mg | CWO | D |
| 78 | B02AA | antifibrinolytika ze skupiny aminokyselin | parent. |
|---|
| 78.1 | B02AA01 | kyselina aminokaproová | parent. | 16 | GM | 65,01 | |
| 78.2 | B02AA02 | kyselina tranexámová | parent. | 2 | GM | 63,74 | |
| 97411 | EXACYL I.V. | inj 5x5ml/500mg | SFH | F |
| 78.3 | B02AA03 | kyselina aminomethylbenzoová | parent. | 0.25 | GM | 196,40 |
| 69793 | PAMBA | inj 5x5ml/50mg | CWO | D |
| 79 | B02AB | antifibrinolytika ze skupiny inhibitorů proteináz | parent. | H |
|---|
| 79.1 | B02AB01 | aprotinin | parent. | 500 | KU | 664,66 | H |
| 02787 | ANTILYSIN SPOFA | inj 5x10ml/100ku | SPX | CZ |
| 80 | B02BA | vitamin K a jeho deriváty a další lokální hemostyptika | p.o. |
|---|
| 80.1 | B02BA01 | fytomenadion | p.o. | 20 | MG | 10,66 |
| 00720 | KANAVIT | gtt 1x5ml 20mg/ml | SLO | SK |
| 80.2 | B02BX01 | etamsylat | p.o. | 0.75 | GM | 29,33 | L/OPH,HEM |
| 81 | B02B | vitamin K a jeho deriváty a další lokální hemostyptika | parent. |
|---|
| 81.1 | B02BA | menadiolfosfat sodná sůl | parent. | 10 | MG | 14,27 | |
| 81.2 | B02BA01 | fytomenadion | parent. | 20 | MG | 15,64 | |
| 00489 | KANAVIT | inj 5x1ml/10mg | HBS | SK |
| 81.3 | B02BX01 | etamsylat | parent. | 0.75 | GM | 83,29 | O/OPH,HEM |
| 02213 | DICYNONE | inj. 100x2ml/250mg | OML | CH |
| 01821 | DICYNONE | inj. 20x2ml/250mg | OML | CH |
| 82 | B02BB | lidský fibrinogen | parent. | U |
|---|
| 82.1 | B02BB01 | lidský fibrinogen | parent. | 5 | GM | 5355,18 | U |
| 52772 | FIBRINOGEN IMMUNO I.V. 1000MG | inj sic 1000mg+50ml | IMM | A |
| 83 | B02BC | lokální hemostatika | lok. |
|---|
| 83.1 | B02BC | lokální hemostatika (rektální lékové formy) | lok. | 1 | DF | 7,19 |
| 88753 | SPOFAX (CIPKY HEMOSTAT.KON.) | sup 5x2.2gm | LEX | CZ |
| 83.2 | B02BC | lokální hemostatika (pěna) | lok. | 1 | C2 | 1,47 |
| 94888 | HYPRO-SORB (60X100X3.5MM) | ext 1ks | HVV | CZ |
| 97230 | HYPRO-SORB O (TVAR TROJUHELN.) | ext 20ks | HVV | CZ |
| 83.3 | B02BC01 | absorbovatelná želatinová houba | lok. | 1 | C2 | 2,69 | |
| 83.4 | B02BC06 | thrombin (houba) | lok. | 1 | DF | 56,80 | |
| 83.5 | B02BC | lokální hemostatika - karboxycelulosa (zásyp) | lok. | 1 | GM | 15,40 | |
| 84 | B02BD | koagulační faktory (faktor VIII a faktor IX) | parent. | B/P |
|---|